Zhejiang Wenda Pharma Technology LTD.

5 clinical trials · Sponsor

Record	Firm	Date
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis (NCT07672561)	Zhejiang Wenda Pharma Technology LTD.	2026-03-18
A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants (NCT06897813)	Zhejiang Wenda Pharma Technology LTD.	2025-06-30
A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis (NCT06912165)	Zhejiang Wenda Pharma Technology LTD.	2024-12-31
A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer (NCT06527300)	Zhejiang Wenda Pharma Technology LTD.	2024-04-25
A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects (NCT06506591)	Zhejiang Wenda Pharma Technology LTD.	2023-10-26

Every clearance here is in the API, with alerts when new ones post.